Trials / Conditions / HTLV-1 Infection
HTLV-1 Infection
4 registered clinical trials studyying HTLV-1 Infection.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Clinico-biological Characterization and Survival of Patients With Adult T-cell Leukemia / Lymphoma (ATL) and P NCT05237245 | Assistance Publique - Hôpitaux de Paris | — |
| Suspended | Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("E NCT04301076 | National Cancer Institute (NCI) | Phase 1 |
| Terminated | Nivolumab in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma NCT03075553 | Mayo Clinic | Phase 2 |
| Completed | Nivolumab in Treating Patients With HTLV-Associated T-Cell Leukemia/Lymphoma NCT02631746 | National Cancer Institute (NCI) | Phase 2 |